We examined the mechanism of the time- and protein synthesis-dependent decline in cardiac mechanical function in isolated working rat hearts. Hearts were perfused with Krebs-Henseleit buffer for 120 min in the presence or absence of the protein synthesis inhibitor cycloheximide (CX; 10 µM). Cardiac work remained stable for 60 min and then spontaneously decreased during 60-120 min of perfusion. This was accompanied by an increase in myocardial inducible nitric oxide synthase (iNOS) and xanthine oxidase (XO) activities and enhanced dityrosine formation in the perfusate, an indicator of peroxynitrite generation. CX markedly attenuated the loss in contractile function and prevented the increase in iNOS and XO activities and dityrosine level. Despite the decline in cardiac work in control hearts, the coupling between tricarboxylic acid (TCA) cycle activity and oxygen consumption remained constant in both groups. ATP, creatine phosphate, and glycogen levels were not different between control and CX groups and did not differ over 120 min of perfusion. We concluded that the delayed and spontaneous loss in myocardial mechanical function in isolated working rat hearts is 1) attenuated by CX treatment, 2) accompanied by a concomitant increase in both iNOS and XO activities and peroxynitrite generation in the heart, and 3) not dependent on a direct impairment in myocardial ATP production, myocardial oxygen consumption, or TCA cycle acetyl-CoA production but may be due to an inefficiency of the heart to utilize ATP for contractile work.

cardiac function; inducible nitric oxide synthase; xanthine oxidase; cycloheximide; energy metabolism

This article has been cited by other articles:

				P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF]

				J. G. Duncan, R. Ravi, L. B. Stull, and A. M. Murphy Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1512 - H1518. [Abstract] [Full Text] [PDF]

				X.-W. Yu, M.-Y. G Liu, R. H Kennedy, and S. J Liu Both cGMP and peroxynitrite mediate chronic interleukin-6-induced negative inotropy in adult rat ventricular myocytes J. Physiol., July 15, 2005; 566(2): 341 - 353. [Abstract] [Full Text] [PDF]

				S. Lancel, S. Tissier, S. Mordon, X. Marechal, F. Depontieu, A. Scherpereel, C. Chopin, and R. Neviere Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2348 - 2358. [Abstract] [Full Text] [PDF]

				W. H. Lee, J. S. Gounarides, E. S. Roos, and M. S. Wolin Influence of peroxynitrite on energy metabolism and cardiac function in a rat ischemia-reperfusion model Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1385 - H1395. [Abstract] [Full Text] [PDF]

				A. K. Grover, S. E. Samson, S. Robinson, and C. Y. Kwan Effects of peroxynitrite on sarcoplasmic reticulum Ca2+ pump in pig coronary artery smooth muscle Am J Physiol Cell Physiol, February 1, 2003; 284(2): C294 - C301. [Abstract] [Full Text] [PDF]

				F. H. Khadour, D. Panas, P. Ferdinandy, C. Schulze, T. Csont, M. M. Lalu, S. M. Wildhirt, and R. Schulz Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1108 - H1115. [Abstract] [Full Text] [PDF]

				P. Ferdinandy and R. Schulz Peroxynitrite: Toxic or Protective in the Heart? Circ. Res., February 2, 2001; 88 (2): e12 - e13. [Full Text] [PDF]

				P. Ferdinandy, H. Danial, I. Ambrus, R. A. Rothery, and R. Schulz Peroxynitrite Is a Major Contributor to Cytokine-Induced Myocardial Contractile Failure Circ. Res., August 4, 2000; 87(3): 241 - 247. [Abstract] [Full Text] [PDF]